Menu Search
Equities

Ikapharmindo Putramas Tbk PT

IKPM:JKT

Ikapharmindo Putramas Tbk PT

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (IDR)280.00
  • Today's Change4.00 / 1.45%
  • Shares traded1.12m
  • 1 Year change+54.70%
  • Beta--
Data delayed at least 10 minutes, as of Nov 08 2024 09:12 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in IDRIncome statement in IDRView more

Year on year Ikapharmindo Putramas Tbk PT had net income fall -7.48% from 16.58bn to 15.34bn despite a 10.63% increase in revenues from 398.73bn to 441.14bn. An increase in the cost of goods sold as a percentage of sales from 54.54% to 57.06% was a component in the falling net income despite rising revenues.
Gross margin45.27%
Net profit margin2.81%
Operating margin6.26%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in IDRView more

In 2023, Ikapharmindo Putramas Tbk PT increased its cash reserves by 306.99%, or 33.41bn. Cash Flow from Financing totalled 52.01bn or 11.79% of revenues. In addition the company generated 25.94bn in cash from operations while cash used for investing totalled 44.54bn.
Cash flow per share6.87
Price/Cash flow per share35.43
Book value per share143.50
Tangible book value per share137.47
More ▼

Balance sheet in IDRView more

Ikapharmindo Putramas Tbk PT has a Debt to Total Capital ratio of 41.43%.
Current ratio1.53
Quick ratio1.25
Total debt/total equity0.7073
Total debt/total capital0.4143
More ▼

Growth rates in IDR

Year on year, growth in earnings per share excluding extraordinary items dropped -7.48%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.